Israel Advances Second MMRV Vaccine Dose to 18 Months Amid Measles Outbreak
How 4 Israeli newsrooms covered this story — translated into English and compared side by side.
First reported by Kikar HaShabbat · 3 hours ago
What happened
Israel's Ministry of Health is advancing the second dose of the MMRV vaccine to 18 months from age six to combat recent measles outbreaks. The change, effective July 1, 2026, aims to provide earlier protection and strengthen herd immunity amid thousands of measles cases and multiple deaths since 2025. Health experts warn vaccine hesitancy remains a challenge despite the updated schedule.
- 01Israel advances second MMRV vaccine dose from age six to 18 months starting July 2026.
- 02Change follows measles outbreaks and aligns with global vaccination practices.
- 03Over 3,800 measles cases reported since April 2025; actual cases estimated at 17,000.
- 04Seventeen deaths and severe neurological complications reported among young children.
- 05Hepatitis A second dose moved from age two to first grade to balance schedule.
- 06Experts warn vaccine hesitancy may limit impact of earlier vaccination.
Summary translated & synthesized from the sources below by baba. Read each original for the full report.
Full coverage · 4 outlets
The same event, reported separately by each newsroom. Open a few to compare what each emphasizes — and what they leave out.
